Fusion peptides with antigens linked to short fragments of invariant chain(cd74)
AssigneesGlaxosmithkline Biologicals SA, University of Copenhagen
InventorsMaria Rosaria BASSI, Riccardo CORTESE, Anna Morena D'ALISE, Antonella FOLGORI, Peter Johannes HOLST, Alfredo NICOSIA
Life of this patent
Estimating the term…
Abstract
The present application provides inter alia a fusion protein comprising a polypeptide wherein the polypeptide consists of a fragment of invariant chain which is operably linked to an antigenic sequence and wherein the fragment of invariant chain consists of a portion of residues 17-97 of SEQ ID NO: 1, wherein the portion comprises at least 5 contiguous residues from residues 77-92 of SEQ ID NO: 1.
Claims19
1-154. (canceled)
A fusion protein, comprising a polypeptide, wherein the polypeptide consists of a fragment of an invariant chain which is operably linked to an antigenic sequence, and wherein the fragment of invariant chain consists of:
- (a) a portion of residues 17-97 of SEQ ID NO:
- 1, wherein the portion comprises at least 5 contiguous residues from residues 77-92 of SEQ ID NO:
- 1;
- (b) 80 residues or fewer and comprises a sequence of at least 5 contiguous residues wherein the sequence shares at least 80% identity with at least 5 contiguous residues from residues 77-92 of SEQ ID NO:
- 1;
- (c) residues 1-97 of SEQ ID NO:
- 1;
- (d) 91 to 103 residues and shares at least 95% identity with residues 1-97 of SEQ ID NO:
- 1;
- (e) residues 17-97 of SEQ ID NO:
- 1;
- (f) 76 to 84 residues and shares at least 95% identity with residues 17-97 of SEQ ID NO:
- 1;
- (g) residues 1-92 of SEQ ID NO:
- 1;
- (h) 88 to 96 residues and shares at least 95% identity with residues 1-92 of SEQ ID NO:
- 1;
- (i) residues 17-92 of SEQ ID NO:
- 1;
- or
- (j) 71 to 79 residues and shares at least 95% identity with residues 17-92 of SEQ ID NO:
- 1.
A polynucleotide encoding a fusion protein, which comprises a polypeptide, wherein the polypeptide consists of a fragment of an invariant chain which is operably linked to an antigenic sequence, and wherein the fragment of invariant chain consists of:
- (a) a portion of residues 17-97 of SEQ ID NO:
- 1, wherein the portion comprises at least 5 contiguous residues from residues 77-92 of SEQ ID NO:
- 1;
- (b) 80 residues or fewer and comprises a sequence of at least 5 contiguous residues wherein the sequence shares at least 80% identity with at least 5 contiguous residues from residues 77-92 of SEQ ID NO:
- 1;
- (c) residues 1-97 of SEQ ID NO:
- 1;
- (d) 91 to 103 residues and shares at least 95% identity with residues 1-97 of SEQ ID NO:
- 1;
- (e) residues 17-97 of SEQ ID NO:
- 1;
- (f) 76 to 84 residues and shares at least 95% identity with residues 17-97 of SEQ ID NO:
- 1;
- (g) residues 1-92 of SEQ ID NO:
- 1;
- (h) 88 to 96 residues and shares at least 95% identity with residues 1-92 of SEQ ID NO:
- 1;
- (i) residues 17-92 of SEQ ID NO:
- 1;
- or
- (j) 71 to 79 residues and shares at least 95% identity with residues 17-92 of SEQ ID NO:
- 1.
A viral vector, comprising a polynucleotide encoding a fusion protein, which comprises a polypeptide, wherein the polypeptide consists of a fragment of invariant chain which is operably linked to an antigenic sequence and wherein the fragment of invariant chain consists of:
- (a) a portion of residues 17-97 of SEQ ID NO:
- 1, wherein the portion comprises at least 5 contiguous residues from residues 77-92 of SEQ ID NO:
- 1;
- (b) 80 residues or fewer and comprises a sequence of at least 5 contiguous residues wherein the sequence shares at least 80% identity with at least 5 contiguous residues from residues 77-92 of SEQ ID NO:
- 1;
- (c) residues 1-97 of SEQ ID NO:
- 1;
- (d) 91 to 103 residues and shares at least 95% identity with residues 1-97 of SEQ ID NO:
- 1;
- (e) residues 17-97 of SEQ ID NO:
- 1;
- (f) 76 to 84 residues and shares at least 95% identity with residues 17-97 of SEQ ID NO:
- 1;
- (g) residues 1-92 of SEQ ID NO:
- 1;
- (h) 88 to 96 residues and shares at least 95% identity with residues 1-92 of SEQ ID NO:
- 1;
- (i) residues 17-92 of SEQ ID NO:
- 1;
- or
- (j) 71 to 79 residues and shares at least 95% identity with residues 17-92 of SEQ ID NO:
- 1.
Dependencies are inferred from the claim text.